Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
MS clinical trials: what can subgroup analyses teach us?
Assessment and Imaging of the Cerebrovascular Glycocalyx.
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
Estrogen and testosterone therapies in multiple sclerosis.
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.
Novartis drug Gilenya® shows long-term efficacy and safety according to new data from extension of phase III head-to-head study
The quality of reports of randomized trials in multiple sclerosis: a review.
Neuroprotection in a novel mouse model of multiple sclerosis.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.
Cuprizone neurotoxicity in the rat: morphologic observations.
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
“Veterinary Medicines” page
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
…
next ›
last »